Table 2.
Measure | Estimate (Interquartile range) | Fraction of all pediatric TB (0–14 years of age) |
---|---|---|
TB incidence | 435,000 (278,000–651,000) | 51.4% |
Isoniazid-resistant TB | 42,200b | 50.2% |
Multidrug-resistant TB | 12,700 (8,020–19,000) | 51.2% |
aAll estimates are from Dodd et al. 2016 [21]
bNote that Dodd et al. 2016 produced an estimate of INH-R TB mono-resistance of 29,500 (IQR: 18,800 - 44,300) cases. The figure presented of 42,200 represents all forms of INH-R (i.e. mono-resistance plus MDR-TB) but because this was not formally estimated in Dodd et al. 2016, there is no IQR around this result